Zevra Therapeutics Inc
F:1GDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zevra Therapeutics Inc
F:1GDA
|
US |
Multiples-Based Value
The Multiples-Based Value for Zevra Therapeutics Inc (1GDA) under the Base Case is 13.65 EUR. Compared with the current market price of 11.25 EUR, the stock appears Undervalued by 18% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.